• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    FDA Removes Partial Clinical Hold On Macrogenics` LINNET Study

    GLOBENEWSWIRE

    Macrogenics Unveils 2025 Financials, Teases Future Data Releases

    GLOBENEWSWIRE

    Macrogenics Halts Gynecologic Cancer Study After Patient Fatality

    BUSINESSWIRE

    Macrogenics Pauses LINNET Trial Enrollment

    GLOBENEWSWIRE

    Macrogenics Joins 8Th Evercore Healthcare Conference

    GLOBENEWSWIRE

    Century, Candel, Macrogenics Call Time On Trials To Save Cash

    FIERCE BIOTECH

    Macrogenics Unveils Q3 2025 Financials & Corporate Advancements

    GLOBENEWSWIRE

    Macrogenics to Present at H.C. Wainwright Global Conference

    GLOBENEWSWIRE

    MacroGenics Reports Q2 2025 Financial Results, Highlights

    GLOBENEWSWIRE

    MacroGenics, Sagard Healthcare Partners in ZYNYZ® Royalty Deal

    GLOBENEWSWIRE

    MacroGenics Updates Corporate Progress and 2024 Financials

    GLOBENEWSWIRE

    MacroGenics pauses work on ADC pending mature survival data

    FIERCE BIOTECH

    MacroGenics Announces Q3 2024 Results Conference Call Date

    GLOBENEWSWIRE

    MacroGenics Enters Agreement With TerSera For MARGENZA®

    BUSINESSWIRE

    TerSera picks up MacroGenics` Margenza for $40M plus milestones

    FIERCE PHARMA

    MacroGenics Shares TAMARACK Study Data On Vobra Duo In mCRPC At ESMO

    GLOBENEWSWIRE

    MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

    GLOBENEWSWIRE

    MacroGenics Achieves $100M Milestone In Incyte Collaboration

    GLOBENEWSWIRE

    MacroGenics Provides Vobramitamab Duocarmazine Update

    GLOBENEWSWIRE

    MacroGenics` stock crashes after 5 deaths in ADC trial

    FIERCE PHARMA

    AbbVie drops MacroGenics-partnered ADC in light of early data

    FIERCE BIOTECH

    MacroGenics Provides Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

    FIERCE BIOTECH

    MacroGenics Announces Preliminary Results from Single Arm Study of Lorigerlimab

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.